Orthofix Medical (OFIX) announced that Massimo Calafiore has been named incoming President and Chief Executive Officer. Calafiore is currently Chief Executive Officer of LimaCorporate, a global orthopedics company, and his appointment to Orthofix is expected to be effective in early 2024, following the completion of LimaCorporate’s previously announced acquisition by Enovis Corporation (ENOV). At that time, Mr. Calafiore is also expected to join Orthofix’s Board of Directors.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Read More on OFIX:
- Orthofix price target lowered to $14 from $16 at Stifel
- Orthofix Medical cuts FY23 revenue view to $739M-$744M, consensus $754.63M
- Orthofix Medical reports Q3 adjusted EPS 7c, consensus (21c)
- Orthofix International (OFIX) Q3 Earnings Cheat Sheet
- Orthofix initiated with a Neutral at Roth MKM
Questions or Comments about the article? Write to editor@tipranks.com